We are live on
!
Find out more
KC
Kenfarb & Co Portfolio holdings
AUM
$109M
1-Year Est. Return
18%
This Fund
S&P 500
This Quarter
Est. Return
-2.66%
1 Year Est. Return
+18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$5.41M
(-4.7%)
Cap. Flow
-$1.5M
Cap. Flow
% of AUM
-1.37%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
216
New
2
Increased
2
Reduced
43
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$275K |
| 2 |
Enbridge
ENB
|
+$130K |
| 3 |
Kenvue
KVUE
|
+$57.2K |
| 4 |
MetLife
MET
|
+$6.23K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$235K |
| 2 |
Eli Lilly
LLY
|
+$211K |
| 3 |
Mastercard
MA
|
+$201K |
| 4 |
Invesco QQQ Trust
QQQ
|
+$134K |
| 5 |
Abbott
ABT
|
+$113K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.44% |
| 2 | Healthcare | 16.32% |
| 3 | Industrials | 11.42% |
| 4 | Consumer Staples | 7% |
| 5 | Utilities | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPL
76
PPL Corp
PPL
$27B
| $349K | 0.32% |
14,800
| – | – |
|
77
GSK
GSK
$104B
| $339K | 0.31% |
9,360
| – | – |
|
78
BCE
BCE
$20.4B
| $317K | 0.29% |
8,300
| – | – |
|
79
Altria Group
MO
$124B
| $307K | 0.28% |
7,300
| – | – |
|
|
K
80
DELISTED
Kellanova
K
| $298K | 0.27% |
5,325
| – | – |
|
81
Shell
SHEL
$242B
| $296K | 0.27% |
4,600
| – | – |
|
82
L3Harris
LHX
$52.5B
| $293K | 0.27% |
1,685
| – | – |
|
|
MMT
83
Aberdeen Multi-Market Income Fund
MMT
$243M
| $289K | 0.26% |
68,000
| – | – |
|
84
PepsiCo
PEP
$187B
| $284K | 0.26% |
1,677
| – | – |
|
85
Southern Company
SO
$107B
| $281K | 0.26% |
4,345
| – | – |
|
86
WD-40
WDFC
$3.31B
| $276K | 0.25% |
1,360
| – | – |
|
87
AT&T
T
$152B
| $272K | 0.25% |
18,125
| – | – |
|
88
American Tower
AMT
$79.2B
| $265K | 0.24% |
1,610
| – | – |
|
89
Alliant Energy
LNT
$19.3B
| $260K | 0.24% |
5,365
-240
| -4% | -$12.4K |
|
90
Becton Dickinson
BDX
$43.6B
| $259K | 0.24% |
1,000
| – | – |
|
91
iShares US Healthcare ETF
IYH
$3.2B
| $251K | 0.23% |
4,645
-500
| -10% | -$27.9K |
|
92
BP
BP
$108B
| $248K | 0.23% |
6,400
| – | – |
|
93
Annaly Capital Management
NLY
$16.9B
| $244K | 0.22% |
13,000
| – | – |
|
94
Kinder Morgan
KMI
$71.9B
| $235K | 0.22% |
14,200
| – | – |
|
|
95
Enbridge
ENB
$124B
| $235K | 0.21% |
7,075
+3,675
| +108% | +$130K |
|
96
Devon Energy
DVN
$50.6B
| $234K | 0.21% |
4,900
| – | – |
|
|
NVO
97
Novo Nordisk
NVO
$223B
| $227K | 0.21% |
2,500
| – | – |
|
98
American Electric Power
AEP
$71.9B
| $222K | 0.2% |
2,953
| – | – |
|
99
Adobe
ADBE
$94.3B
| $221K | 0.2% |
434
| – | – |
|
100
Charter Communications
CHTR
$16.2B
| $220K | 0.2% |
500
| – | – |
|
Similar funds
QT
SA
FHCM
MAP
GG
AEPLI
DCS
ASA
Kenfarb & Co's Q3 2023 Portfolio in Review
As of Q3 2023, Kenfarb & Co held 216 positions worth $109M, down 4.7% from $115M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 2.3%. Kenfarb & Co opened 2 new positions and exited 3, leaving the 216-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Kenfarb & Co's largest Q3 2023 buy was Kenvue: 2,471 shares worth $49.6K.
- Kenfarb & Co added most to Verizon in Q3 2023, an estimated $275K increase.
- Kenfarb & Co's biggest Q3 2023 reduction was Microsoft, cutting an estimated $235K.
- Kenfarb & Co fully exited Stryker in Q3 2023, selling an estimated $76.3K.
- Kenfarb & Co's ten largest holdings make up 33% of its $109M portfolio in Q3 2023.
- Kenfarb & Co opened 2 new positions and closed 3 in Q3 2023.
- Kenfarb & Co's portfolio value fell 4.7% quarter-over-quarter to $109M.
Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.